Azithromycin or montelukast as inhaled corticosteroid–sparing agents in moderate-to-severe childhood asthma study
- 31 December 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 122 (6), 1138-1144.e4
- https://doi.org/10.1016/j.jaci.2008.09.028
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Attenuation of the September Epidemic of Asthma Exacerbations in Children: A Randomized, Controlled Trial of Montelukast Added to Usual TherapyPEDIATRICS, 2007
- Side-effects of fluticasone in asthmatic children: no effects after dose reductionEuropean Respiratory Journal, 2004
- Mycoplasma pneumoniae and Asthma in ChildrenClinical Infectious Diseases, 2004
- Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma.European Respiratory Journal, 2004
- Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosaJAMA, 2003
- Trial of Roxithromycin in Subjects with Asthma and Serological Evidence of Infection withChlamydia pneumoniaeAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Anti‐inflammatory effects of macrolides in lung disease*Pediatric Pulmonology, 2001
- Inhaled Corticosteroid Reduction and Elimination in Patients With Persistent Asthma Receiving SalmeterolA Randomized Controlled TrialJAMA, 2001
- Increased Frequency of Chlamydia pneumoniae Antibodies in Patients with AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children.1990